scispace - formally typeset
B

Badri N. Pandey

Researcher at Homi Bhabha National Institute

Publications -  110
Citations -  3009

Badri N. Pandey is an academic researcher from Homi Bhabha National Institute. The author has contributed to research in topics: Apoptosis & Cancer. The author has an hindex of 28, co-authored 106 publications receiving 2511 citations. Previous affiliations of Badri N. Pandey include Bhabha Atomic Research Centre & Rutgers University.

Papers
More filters
Journal ArticleDOI

Synthesis of oleic acid functionalized Fe3O4 magnetic nanoparticles and studying their interaction with tumor cells for potential hyperthermia applications.

TL;DR: The efficacy of MN-OA in killing of tumor cells by cellular hyperthermia is suggested and a new approach to achieve dispersion of OA functionalized MN (MN-OA) in aqueous medium using sodium carbonate is employed, which improves their biological applicability.
Journal ArticleDOI

Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug

TL;DR: The results suggest that Triphala possessed ability to induce cytotoxicity in tumor cells but spared the normal cells, and the substantial regression of transplanted tumor in mice fed withTriphala points to its potential use as an anticancer drug for clinical treatment.
Journal ArticleDOI

Cytokine profile of conditioned medium from human tumor cell lines after acute and fractionated doses of gamma radiation and its effect on survival of bystander tumor cells

TL;DR: Comparisons and subtle differences in basal and radiation-induced cytokine profile of different tumor cell lines are revealed, and its influence on growth and survival of respective bystander cells may add a new dimension to the current understanding about role of cytokines in cancer biology.
Journal ArticleDOI

Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity.

TL;DR: In this article, the role of cellular redox and redox sensitive transcription factor, Nrf2 in the radiosensitivity of prostate cancer cell lines PC3 and DU145, has been investigated.